Feedback / Questions
PTG-200 - Protagonist Therapeutics, J&J
PTG-200: Data from P2 PRISM trial (NCT04102111) for Crohn's disease in H1 2021
(Protagonist Therapeutics)
-
Feb 6, 2020 -
Corporate Presentation
P2 data
http://investors.protagonist-inc.com/static-files/606743d7-ec47-46d5-985e-df29839f9dbc
Feb 6, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious